The markets closed lower with the Dow losing 25 points to 20,812 ahead of president Donald Trump's first address before a joint session of Congress. Nasdaq fell 36 points to 5,825.
On the upside
Kite Pharma (Nasda: KITE) reported positive results from a primary analysis of ZUMA-1 for axicabtagene ciloleucel to treat chemorefractory aggressive B-cell non-Hodgkin lymphoma.
LSB Industries (NYSE: LXU) widened losses for the fourth quarter but the company expects performance to improve in 2017.
Nutrisystem (Nasdaq: NTRI) impressed with sharply higher fourth quarter earnings that more than doubled to top analyst estimates.
On the downside
Essendant (Nasdaq: ESND) reported a loss for the fourth quarter as revenue slipped.
Fourth quarter earnings plunged for Fiesta Restaurant Group (Nasdaq: FRGI) and the company named a new chief executive who has suspended discussions to sell the company.
Ophthotech (Nasdaq: OPHT) widened fourth losses significantly.
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 3 on the NYSE and by nearly 7 to 2 on Nasdaq. The broader S&P 500 index fell 6 points to 2,363. Bitcoin slipped $2 to $1,183.
